From: Mesenchymal stem cells-derived exosomes for drug delivery
Aim | Exosomes origin | Loading methods | Administration route | Model | Protein | References |
---|---|---|---|---|---|---|
Ameliorate cerebral ischemia–reperfusion injury | ADSCs | Overexpression | Local injection | Mice | PEDF | [42] |
Improve cardiac regeneration | HucMSCs | Transfection | Intravenous injection | Mice | Akt | [121] |
Anti-tumor | MSC | Electroporation | In vitro cell experiment | N/A | TNF-α | [123] |
Anti-tumor | BMSCs | Transfection | Intravenous injection | Mice | TRAILâ‘ | [126] |
Cystic fibrosis | BMSCs | Transfection | In vitro cell experiment | N/A | Zinc Finger Protein | [128] |
Prevent cisplatin injury | HucMSC | Transfection | In vitro cell experiment | N/A | 14–3-3protein | |
Enhance angiogenesis | HucMSCs | Overexpression | Subcutaneous injection | Mice | Angiopoietin-2 | [122] |